Go Pro

Matinas Biopharma (MTNB) News Today

Matinas Biopharma logo
$0.20 0.00 (0.00%)
As of 08/28/2026 04:10 PM Eastern

Matinas Biopharma Latest News

Matinas BioPharma Holdings, Inc.
MTNB Matinas BioPharma Holdings, Inc. - Seeking Alpha
Matinas BioPharma Holdings, Inc. (MTNB) - Yahoo Finance
Matinas BioPharma files to sell 16.9M shares of common stock for holders
Matinas BioPharma appoints Murphy, Neugeboren to board of directors
Matinas BioPharma appoints Evelyn D’An to board of directors
111 Equity Group increases stake in Matinas BioPharma
Matinas BioPharma Receives NYSE Noncompliance Notice
Matinas BioPharma Faces Uncertain Future After Halting MAT2203 Development
Matinas BioPharma downgraded to Hold from Buy at Maxim
Matinas BioPharma says MAT2203 partnership negotiations terminated
Matinas BioPharma enacts reverse stock split
Matinas BioPharma Holdings Inc (6LJ.DU)
MTNB Stock Earnings: Matinas BioPharma Hldgs Meets EPS for Q2 2024

Matinas Biopharma Media Mentions By Week

Matinas Biopharma Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MTNB
News Sentiment

1.00

0.94

Average
Healthcare
News Sentiment

Matinas Biopharma News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MTNB Articles
This Week

1

0

MTNB Articles
Average Week

Matinas Biopharma Trends on MarketBeat

This week vs. last week
Page Views
815
-4%
Get Matinas Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for MTNB and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Matinas Biopharma dated 7/13/2026.
From Our Partners